期刊
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
卷 53, 期 3, 页码 483-489出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jpba.2010.05.022
关键词
UPLC; Valsartan; Forced degradation; Validation; Stability-indicating
资金
- Dr. Reddy's Group
A simple, precise, accurate stability-Indicating gradient reverse phase ultra-performance liquid chromatographic (RP-UPLC) method was developed for the quantitative determination of purity of Valsartan drug substance and drug products in bulk samples and pharmaceutical dosage forms in the presence of its impurities and degradation products. The method was developed using Waters Agility BEH C18 (100 mm x 2 1 mm, 1 7 mu m) column with mobile phase containing a gradient mixture of solvents A and B. The eluted compounds were monitored at 225 nm, the run time was within 9.5 min, which Valsartan and its seven impurities were well separated Valsartan was subjected to the stress conditions of oxidative. acid, base, hydrolytic, thermal and photolytic degradation. Valsartan was found to degrade significantly in acid and oxidative stress conditions and stable in base, hydrolytic and photolytic degradation conditions The degradation products were well resolved from main peak and its impurities, proving the stability-indicating power of the method The developed method was validated as per international conference on harmonization (ICH) guidelines with respect to specificity, linearity, limit of detection, lima of quantification, accuracy, precision and robustness This method was also suitable for the assay determination of Valsartan in pharmaceutical dosage forms (c) 2010 Elsevier B V All rights reserved
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据